Galectin Therapeutics (NASDAQ: GALT)

Posted by iNoticiero on lunes, 22 de julio de 2019 0

• http://www.twitter.com/galectingalt
• http://www.linkedin.com/company/galectin-therapeutics
• http://galectintherapeutics.com/
• http://galectintherapeutics.com/who-we-are/about-us/
• http://galectintherapeutics.com/who-we-are/leadership/
• http://galectintherapeutics.com/what-we-do/develop-proprietary-compounds-for-disease/pipeline/
• http://galectintherapeutics.com/newsroom/
• http://investor.galectintherapeutics.com/
• http://investor.galectintherapeutics.com/press-releases
• http://investor.galectintherapeutics.com/events-and-presentations
• http://investor.galectintherapeutics.com/corporate-governance
• http://investor.galectintherapeutics.com/management
• http://investor.galectintherapeutics.com/corporate-governance/board-of-directors
• http://investor.galectintherapeutics.com/corporate-governance/committee-composition
• http://investor.galectintherapeutics.com/financial-information
• http://investor.galectintherapeutics.com/financial-information/sec-filings
• http://investor.galectintherapeutics.com/financial-information/annual-reports
• http://investor.galectintherapeutics.com/financial-information/quarterly-results
• http://investor.galectintherapeutics.com/stock-information
• http://investor.galectintherapeutics.com/stock-information/historic-stock-lookup
• http://investor.galectintherapeutics.com/stock-information/analyst-coverage
• http://investor.galectintherapeutics.com/investor-faqs
• http://galectintherapeutics.com/contact-us/
• http://galectintherapeutics.com
• http://perspectives.galectintherapeutics.com/
• http://galectintherapeutics.com/what-we-do/develop-proprietary-compounds-for-disease/
• http://www.newsweek.com/2016/02/12/nash-deadly-liver-disease-obesity-big-pharma-421363.html
• http://investor.galectintherapeutics.com/news-releases/news-release-details/galectin-therapeutics-raises-445-million-rights-offering-and-25
• http://investor.galectintherapeutics.com/news-releases/news-release-details/galectin-therapeutics-reports-alternate-price-common-stock
• http://investor.galectintherapeutics.com/news-releases/news-release-details/galectin-therapeutics-releases-richard-e-uihleins-open-letter-0
• http://galectintherapeutics.com/wp-content/uploads/2019/03/GALT%20Investor%20Presentation%20NASH%20Only%20March%202019%20FINAL.pdf
• http://galectintherapeutics.com/wp-content/uploads/2018/04/galectin-therapeutics-2018-easl-presentation-4-12-18.pdf
• http://galectintherapeutics.com/wp-content/uploads/2018/04/galectin-therapeutics-nash-summit-presentation-4-25-18.pdf
• http://galectintherapeutics.com/wp-content/uploads/2018/07/2018-Galectin-Presentation-Immunooncology-FINAL.pdf
• http://investor.galectintherapeutics.com/financials.cfm
• http://galectintherapeutics.com/wp-content/uploads/2018/08/galectin-media-factsheet_07-31-2018.pdf
• http://galectintherapeutics.com/terms-of-use/#fls